Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

610 ARTÍCULOS , VIENDO DEL 301 AL 315

Use of anti-amyloid-β monoclonal antibodies in persons with Down syndrome Alzheimer's disease

Farrell C, Saini F, Beidas MM, Ryan NS, Strydom A, Wiseman FK.

Alzheimers Dement. 2026 Apr;22(4):e71404. doi: 10.1002/alz.71404.

Do ward changes affect outcomes differently in people living with dementia?

Elliott E, Hamilton R, Munford L, Richardson C, Darley L, Thompson R, Rowbotham D, Vardy ERLC.

Age Ageing. 2026 Jan 3;55(1):afaf372. doi: 10.1093/ageing/afaf372.

Sensitivity comparison of longitudinal cognitive function indicators of Alzheimer's disease after mild cognitive impairment: a prospective cohort study

Guo G, Song W, Wang A, Cui Q, Yang X, Wang Y, Ma Y, Han H, Li Z, Zhang Z, Meng W, Wang S, Shi F.

Sci Rep. 2026 Mar 22;16(1):14503. doi: 10.1038/s41598-026-44192-2.

Long-term effect of transcranial magnetic stimulation and transcranial electrical stimulation in primary progressive aphasia: study protocol for a randomised, double-blind clinical trial (RECONNECT-PLUS)

Fernández-Romero L, Díez-Cirarda M, Delgado-Alonso C, Cabrera-Martin MN, González-Rosa JJ, Sanz-Nieto C, Pérez-Macías N, Balugo P, Gómez-Ruiz N, Matias-Guiu J, Portolés-Pérez A, Matias-Guiu JA.

BMJ Open. 2026 May 20;16(5):e112999. doi: 10.1136/bmjopen-2025-112999.

Neural substrates of cognitive frailty as a high-risk factor for dementia compared with mild cognitive impairment: A multimodal magnetic resonance imaging study

Harada K, Morikawa M, Fujii K, Nishijima C, Kakita D, Soma K, Okuya T, Shimada H.

Arch Gerontol Geriatr. 2026 May;144:106171. doi: 10.1016/j.archger.2026.106171. Epub 2026 Feb 16.

[Epidemiological studies of the association between dyslipidemia and Alzheimer's disease]

Tong FF, Huang RQ, Gao Y, Luo QQ, Chen YP, Xu GZ.

Zhonghua Liu Xing Bing Xue Za Zhi. 2026 Apr 10;47(4):767-774. doi: 10.3760/cma.j.cn112338-20250727-00528.

Management of Concomitant Mental Health Conditions in Older Adults with Cognitive Impairment

Tunink C, Ulen M, McNair SH.

Prim Care. 2026 Jun;53(2):281-293. doi: 10.1016/j.pop.2026.01.010. Epub 2026 Apr 7.

A phase 2, randomized, multicenter, double-blind, placebo-controlled trial of S-adenosyl methionine in participants with mild cognitive impairment or dementia due to Alzheimer's disease

Holper S, Barnham KJ, Churilov L, Yates P, Brodtmann A, Johns S, Li QX, Bhalala O, Chin KS, Loveland P, Yu JJ, Masters CL, Watson R, Yassi N.

Alzheimers Dement. 2026 Apr;22(4):e71381. doi: 10.1002/alz.71381.

Effects of a complex intervention on agitation and aggression in people living with dementia and mild cognitive impairment in shared-housing arrangements: results for a secondary outcome of the multicenter, cluster-randomized controlled DemWG study

Donath C, Kratzer A, Graessel E, Keck A, Günay S, Altona J, Misonow J, Stiefler S, Schmidt A, Wolf-Ostermann K.

BMC Psychiatry. 2026 Jan 24;26(1):88. doi: 10.1186/s12888-026-07810-x.

Clinical and behavioral predictors of HIV-associated neurocognitive disorder among people with HIV who use substances: a secondary analysis of the HOPE trial

Wang G, Yang X, Wang K, Li X, Dai Z, Qiao S.

J Neurovirol. 2026 May 7;32(3):18. doi: 10.1007/s13365-026-01315-9.

Cost-effectiveness of multimodal intervention for the prevention of dementia in Japan

Takashi N, Ohtera S, Kuroda Y, Arai H, Sakurai T; J-MINT investigators.

J Prev Alzheimers Dis. 2026 Feb;13(2):100460. doi: 10.1016/j.tjpad.2025.100460. Epub 2026 Jan 1.

Validation of the Turkish Version of the DDQ-30: Norms and Clinical Utility for Detecting Lexical-Semantic Impairments

Karalı FS, Tosun S, Eskioğlu Eİ, Dicle M, Çavdar D, Çınar N, Macoir J.

Arch Clin Neuropsychol. 2026 Jan 30;41(1):acaf093. doi: 10.1093/arclin/acaf093.

Mixed primary progressive aphasia and alcohol use disorder: a case of detailed clinical phenotyping outperforming molecular imaging

Okoye O, Aguzzoli CS, Battista P, Ramos C, Meenan K, Abu Raya M, Ratnasiri B, Rojas JC, de Leon J, Miller B, Gorno-Tempini ML, La Joie R, Spina S.

Neurocase. 2026 Feb;32(1):29-39. doi: 10.1080/13554794.2026.2623906. Epub 2026 Feb 18.

Therapeutic Options for Alzheimer's Disease and Aging-Associated Cognitive Decline: State of the Art in the ACH2.0 Paradigm

Volloch V, Rits-Volloch S.

Int J Mol Sci. 2026 Feb 2;27(3):1486. doi: 10.3390/ijms27031486.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias